| Not Yet Recruiting | A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations Hepatic Insufficiency, Renal Insufficiency, Elderly | Phase 4 | 2026-01-30 |
| Not Yet Recruiting | Drug-drug Interaction Study of Rifampin and Anaprazole Sodium Drug-drug Interaction Study | Phase 4 | 2026-01-04 |
| Recruiting | A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. Reflux Esophagitis (RE) | Phase 3 | 2025-07-30 |
| Unknown | A Study of the Absorption, Metabolism and Excretion of [14C]XZP-3621 in Human Healthy Volunteers | Phase 1 | 2023-05-01 |
| Not Yet Recruiting | A Study of KM602 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-04-01 |
| Not Yet Recruiting | A Study of KM501 in Patients With Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-04-01 |
| Recruiting | A Study of XZB-0004 in Patients With Solid Tumors Advanced Solid Tumor, NSCLC | Phase 1 | 2023-03-24 |
| Unknown | To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS AML, MDS | Phase 1 | 2023-02-01 |
| Unknown | A Study of Anaprazole Sodium Enteric-coated Tablets in the Treatment of Reflux Esophagitis Reflux Esophagitis, Gastroesophageal Reflux, Esophagitis | Phase 2 | 2022-12-01 |
| Unknown | Drug-drug Interaction Study of XZP-3621 Tablet Healthy Subjects | Phase 1 | 2022-11-15 |
| Unknown | A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLC ALK-positive NSCLC | Phase 2 | 2022-09-01 |
| Unknown | A Clinical Trial of XZP-3287 for Material Balance Healthy Male Subjects | Phase 1 | 2022-08-02 |
| Not Yet Recruiting | A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. Advanced Solid Tumor | Phase 1 | 2022-04-01 |
| Active Not Recruiting | A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer Advanced Breast Cancer | Phase 3 | 2022-03-14 |
| Unknown | A Study to Evaluate and Compare the Efficacy and Safety of XZP-3621 Versus Crizotinib Non-small Cell Lung Cancer | Phase 3 | 2022-02-07 |
| Completed | Food Effect and Mass Balance Study of XZP-3621 Tablets Healthy | Phase 1 | 2021-12-23 |
| Recruiting | A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-12-06 |
| Unknown | A Clinical Trial of XZP-6019 Tablets in Healthy Subjects Non-alcoholic Fatty Liver Disease | Phase 1 | 2021-11-30 |
| Active Not Recruiting | A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer Advanced Breast Cancer | Phase 3 | 2021-11-16 |
| Unknown | Effect of Food on the Pharmacokinetics of XZP-3287 in Healthy Subjects Healthy | Phase 1 | 2021-08-01 |
| Unknown | Effect of Clarithromycin and Rifampicin on the Pharmacokinetics of XZP-3287 in Healthy Subjects Healthy | Phase 1 | 2021-07-01 |
| Unknown | A Phase I Clinical Trial of XZP-5610 Tablets in Healthy Subjects Nonalcoholic Steatohepatitis (NASH) | Phase 1 | 2021-05-31 |
| Completed | A Phase I Study of XZP-3621 in Chinese Patients With ALK or ROS1 Rearrangement Non-small Cell Lung Cancer ROS1 Rearrangement Non-small Cell Lung Cancer, ALK Rearrangement Non-small Cell Lung Cancer | Phase 1 | 2019-03-12 |